Hasapis, Stephanie
Caraballo, Isibel
Sears, Timothy J.
Brock, Kennedy D.
Cart, John B.
Moding, Everett J.
Lee, Chang-Lung
Funding for this research was provided by:
My Blue Dots organization
National Cancer Institute (K99CA212198)
National Institutes of Health (U19AI067798)
Article History
Received: 4 October 2022
Accepted: 28 July 2023
First Online: 9 August 2023
Competing interests
: C-LL reports research supports from Janssen R&D and Rythera Therapeutics; however, this interest does not present a conflict with the content in this manuscript. The remaining authors have no conflicting financial interests.